Tevamera - Company finances
|
EUR
|
2019
From: 2019-12-18
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|
|
Financial data
|
|||||||
| Sales revenue | - | 0 | 15,471 | 43,845 | 44,958 | 44,985 | 41,014 |
| Profit before tax | 0 | 0 | -1,957 | -242 | -18,728 | 1,222 | -3,257 |
| Net profit | 0 | 0 | -1,957 | -242 | -18,728 | 1,161 | -3,257 |
| Equity | 2,500 | 2,500 | 537 | 295 | -16,228 | 2,041 | -1,215 |
| Liabilities | 0 | 0 | 932 | 8,135 | 22,286 | 2,594 | 2,951 |
| Non-current assets | 0 | 0 | 0 | 4,947 | 4,417 | 3,887 | 0 |
| Current assets | 2,500 | 2,500 | 1,469 | 3,483 | 1,641 | 748 | 1,736 |
| Total assets | 2,500 | 2,500 | 1,469 | 8,430 | 6,058 | 4,635 | 1,736 |
|
Taxes paid
|
|||||||
| STI taxes | - | - | - | - | 6,297 | 6,599 | 5,841 |
| Social insurance contributions | - | - | - | - | 7,525 | 3,086 | 2,486 |
|
Financial indicators
|
|||||||
| Revenue change y/y | - | - | - | +183.4% | +2.5% | +0.1% | -8.8% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 0.0% | -133.2% | -2.9% | -309.1% | 25.0% | -187.6% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 0.0% | -364.4% | -82.0% | - | 56.9% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | -12.6% | -0.6% | -41.7% | 2.6% | -7.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | -12.6% | -0.6% | -41.7% | 2.7% | -7.9% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | 1.7 | 27.6 | - | 1.3 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 5,157 | 10,961 | 8,174 | 10,796 | 11,718 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Tevamera - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-09-24 | 2025-10-08 | 122.87 |
| 2025-09-16 | 2025-09-23 | 124.58 |
| 2024-12-17 | 2024-12-20 | 2.07 |
| 2023-06-16 | 2023-06-19 | 592.01 |
| 2022-12-16 | 2022-12-26 | 14.98 |
| 2022-11-21 | 2022-12-14 | 18.53 |
| 2022-11-17 | 2022-11-18 | 18.53 |
| 2022-10-26 | 2022-10-27 | 346.46 |
| 2022-10-18 | 2022-10-19 | 346.46 |
| 2022-01-18 | 2022-01-18 | 79.05 |
| 2021-11-18 | 2021-11-18 | 87.37 |
| 2021-11-16 | 2021-11-17 | 270.85 |
| 2021-10-18 | 2021-10-19 | 233.32 |
Tevamera - VMI tax arrears
As of 2026-09-19, the amount of overdue STI tax debt of the company Tevamera is: 1 €
| From | To | Overdue, € |
|---|---|---|
| 2026-05-18 | 2026-09-19 | 1.0 |
| 2026-05-17 | 2026-05-17 | 327.48 |
| 2026-02-21 | 2026-05-16 | 1.0 |
| 2026-01-29 | 2026-02-16 | 1.42 |
| 2026-01-18 | 2026-01-28 | 14.11 |
| 2026-01-17 | 2026-01-17 | 335.89 |
| 2025-08-01 | 2026-01-16 | 0.08 |
| 2025-07-31 | 2025-07-31 | 0.04 |
| 2025-07-03 | 2025-07-30 | 0.28 |
| 2025-07-01 | 2025-07-02 | 70.28 |
| 2025-06-19 | 2025-06-30 | 70.0 |
| 2025-06-18 | 2025-06-18 | 9.0 |
| 2025-06-17 | 2025-06-17 | 335.03 |
| 2025-02-20 | 2025-06-16 | 9.0 |
| 2024-07-02 | 2025-02-19 | 8.0 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Tevamera, UAB (code 305399990) is a Private Limited Liability Company engaged in new construction. In the latest financial year, 2025, the company generated revenue of €41.0K, down 8.8% year on year from €45.0K in 2024. The revenue trend has been relatively stable but slightly weaker over the three-year period, with €45.0K in both 2023 and 2024 before the decline in 2025. Profitability was volatile: the company recorded a net loss of €18.7K in 2023, a net profit of €1.2K in 2024, and a net loss of €3.3K in 2025. The 2025 profit margin was -7.9%. Balance sheet values also remained modest, with total assets of €1.7K, equity of -€1.2K and liabilities of €3.0K at year-end 2025. The capital structure therefore remained weak, with negative equity. Asset turnover was high at 23.63x, reflecting a relatively large revenue base compared with assets. Revenue per employee was €13.7K, while profit per employee was -€1.1K.